To: Pierre Borczuk who wrote (76 ) 7/10/2000 10:51:10 AM From: Marc Phelan Read Replies (1) | Respond to of 201 Good News SAN DIEGO, Jul 7, 2000 (BW HealthWire) -- Company Launching Proprietary Technology with Internet-Based Information Management Capabilities CardioDynamics International Corporation (Nasdaq: CDIC), manufacturer of BioZ(R) noninvasive digital cardiac function monitoring systems, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new BioZ.pc(TM) System. The Internet-ready BioZ.pc combines the Company's proprietary noninvasive Impedance Cardiography (ICG) technology with the wide-spread capabilities of the Internet. Michael K. Perry, CardioDynamics Chief Executive Officer, stated, "The BioZ.pc is the first product from our platform development program that is being leveraged into future ICG systems, modules, and additional medical company products. The BioZ.pc combines our proprietary measurement capabilities with a laptop computer, which then transmits the results to a central file server. The physician can review the transmitted patient data via the Internet or electronic fax. We are pleased to continue our record of fast-track product development and rapid FDA clearances, which are important in capitalizing on healthcare market needs." The BioZ.pc will assist in expanding CardioDynamics' market reach by providing noninvasive cardiac function data to physicians who would not otherwise purchase a stand alone BioZ device. The BioZ.pc is expected to be launched during the Company's fiscal third quarter and will be marketed by Profiles in Health as a component to their Proveillance(TM) System. PS: Why are we in the "Five Dollars and Under" section?